VADIM P. KOSHENKOV, MD

Plain English
This study looked at two tools designed to predict whether patients with melanoma would have a positive sentinel lymph node biopsy, which is important for treatment decisions. Out of 532 patients studied, 98 (about 18.4%) had a positive biopsy result. The research found that the Memorial Sloan Kettering tool was better for patients aged 75 and older, while the Melanoma Institute Australia tool was more effective for those with a higher rate of cell division. However, both tools struggled to accurately predict positive results in younger patients. Who this helps: This research benefits doctors and healthcare providers by helping them choose the right prediction tool based on patient age and characteristics.

Plain English
Researchers studied melanoma cases to find out how often patients' tumor stages were upgraded after surgery. They looked at data from over 133,000 patients and found that about 5.2% experienced an increase in stage, with higher rates seen in older men, non-White individuals, and those with lower education levels. This is important because knowing who is at higher risk for upstaging can help doctors provide better care and decide if further surgery is needed. Who this helps: This helps patients and doctors by identifying those who might need closer monitoring and additional treatment.

Plain English
This study looked at how COVID-19 changed the way melanoma patients were treated in the Northeast U.S. After the pandemic lockdown, 17% fewer melanoma patients were treated, and more patients presented with advanced-stage diseases, jumping from 7.1% to 27.5% for stage III-IV melanoma in just two months. This trend matters because it indicates that delays in treatment and screening could worsen health outcomes for melanoma patients. Who this helps: This helps patients and healthcare providers by highlighting the need for ongoing cancer screening and care during public health crises.

Plain English
This study looked at a test called the Decision-Dx Melanoma (DDM) 31-gene assay, which aims to determine the risk of melanoma returning in patients diagnosed with early-stage skin cancer. Researchers analyzed data from 361 patients, finding that 13.6% experienced a recurrence of melanoma, while 8% had it spread to distant areas. The study revealed that patients in the highest-risk genetic group had a much lower chance of remaining cancer-free after 5 years (45% compared to 75% for low-risk patients), indicating that while genetic testing provides valuable insights, traditional tumor factors like thickness still play a crucial role in predicting outcomes. Who this helps: This helps patients and doctors make informed decisions about monitoring and treatment after a melanoma diagnosis.

Plain English
This study looked at a 61-year-old woman who had both melanoma on her back and breast cancer at the same time. The doctors used a team approach to plan surgery, carefully considering how the cancers could affect each other. They successfully removed both cancers and examined nearby lymph nodes, which is important for determining potential spread. This case is significant because it shows how a coordinated team can effectively manage rare cases where a patient has two cancers at once, providing valuable insights for future treatments. Who this helps: This helps doctors and patients facing complex cancer diagnoses.

Plain English
This study looked at ways to more accurately predict whether patients with skin melanoma have cancer that has spread to their lymph nodes. By combining traditional clinical information with a new test based on a 31-gene profile, researchers found that their method could better identify which patients are less likely to have cancer spread, increasing the accuracy of predictions from 8.5% to 27.7% for those with a low risk. This is important because it could lower unnecessary procedures while ensuring that patients more likely to have spread are properly evaluated. Who this helps: Patients with melanoma and their doctors.

Plain English
Doctors treated a 63-year-old man with a rare cancer (leiomyosarcoma) that started in a major vein in his abdomen and had unexpectedly grown into his aorta (the largest artery). They removed the entire tumor and surgically rebuilt both the vein and artery using grafts, using a special bypass technique to keep blood flowing during surgery. The patient recovered well and remained cancer-free a year later with both grafts working properly. This case shows that when this rare cancer involves both the vein and artery, surgeons can successfully remove it and rebuild both vessels if the patient is healthy enough to handle the complex operation.

Plain English
This study looked at how well older patients, specifically those aged 80 and over, do after undergoing surgery for esophageal cancer compared to younger patients. Researchers found that octogenarians had similar hospital stays and complications rates to younger patients, with a hospital stay of 18 days and a 9% chance of dying shortly after surgery. However, their long-term survival rates were lower, with only 37% living 5 years after the surgery compared to younger patients. Who this helps: This research benefits doctors and healthcare providers making decisions about surgery options for elderly cancer patients.

Plain English
This paper looks at how surgery is used to treat melanoma, a type of skin cancer, and how techniques have evolved over the years. It highlights the importance of a specific surgical procedure called sentinel lymph node biopsy (SLNB), which helps determine the spread of the cancer and can give patients a better chance of being cured. The study emphasizes that timely and appropriate surgical care is crucial for patients, particularly those with early-stage melanoma. Who this helps: Patients with melanoma and their doctors benefit from these insights.

Plain English
This study looked at a rare problem called tracheobronchial injury that can happen during esophagectomy surgery for cancer. Out of 425 patients, 7 (1.6%) suffered this injury, often happening to older patients with certain types of tumors. The findings showed that patients with this injury faced a 75% death rate if the injury was found after surgery, highlighting the need for quick and aggressive treatment if these injuries are discovered later. Who this helps: This research benefits doctors and surgeons managing patients undergoing esophagectomy for cancer.

Plain English
The research focuses on squamous cell carcinoma of the skin (SCCS), a type of skin cancer that can become severe when it spreads. The study highlights the increasing number of cases due to more people aging and higher exposure to sunlight, revealing a critical need for better treatment options. It mentions that current treatments, like combinations of chemotherapy and certain targeted therapies, show promise but lack thorough testing, signaling a need for more studies. Who this helps: This helps patients with advanced skin cancer and doctors seeking effective treatment options.

Plain English
This study explored how a signaling pathway called Notch affects a type of esophageal cancer, which has been increasing in frequency and is responsible for many deaths worldwide. The researchers found that Notch signaling contributes to the cancer's ability to resist treatment, and blocking this signaling with a specific drug reduced tumor size in models derived from patients. This is important because it suggests a new way to treat esophageal adenocarcinoma, potentially leading to more effective therapies. Who this helps: Patients with esophageal adenocarcinoma.

Plain English
This study looked at patients undergoing surgery to remove the gallbladder for non-cancerous issues to see how often unexpected gallbladder cancer was found during the procedure. Researchers found that 67 out of 201 patients had incidental gallbladder cancer, with those aged 65 and older being ten times more likely to have cancer. Other factors indicating higher cancer risk included dilated bile ducts and thickened gallbladder walls. Understanding these risk factors can help surgeons take extra precautions during surgery to prevent complications related to undetected cancer. Who this helps: This helps surgeons and patients by improving pre-surgery assessments and reducing risks during gallbladder surgeries.

Plain English
This study looked at the results of a minimally invasive surgery called laparoscopic splenectomy (LS) in patients with very large spleens, specifically those defined as massive or supramassive. The researchers found that LS led to less blood loss (308 mL) and a shorter hospital stay (3 days) compared to traditional open surgery (400 mL and 4.5 days), although it took longer to perform (195 minutes). Overall, LS was shown to provide better outcomes for patients with large spleens while having similar rates of complications. Who this helps: Patients with massive or supramassive spleens needing surgery.

Plain English
This study looked at a rare cause of portal hypertension, which is high blood pressure in the liver caused by nodular regenerative hyperplasia (NRH). The researchers treated a young patient with NRH using a specific surgical method called a distal splenorenal shunt, which is effective and has a low risk of liver failure afterward. The findings are important because they highlight a safe treatment option for patients with this uncommon condition that can lead to serious complications. Who this helps: This helps patients with nodular regenerative hyperplasia of the liver.

Plain English
This study looked at melanoma patients with thin tumors that had positive deep margins and compared them to patients with thicker tumors. Researchers found that 8.3% of patients with thin melanomas and positive margins had cancer spread to lymph nodes, while 9.0% of those with thicker tumors had the same outcome, which shows similar risk levels. This is important because it suggests that surgeons should take into account positive deep margins when deciding if patients need further testing for cancer spread. Who this helps: This helps melanoma patients and doctors understand the risks associated with thin melanomas that have positive margins.

Plain English
This study looked at how to improve treatment for gastrointestinal stromal tumors (GISTs) using medications called tyrosine kinase inhibitors (TKIs), like imatinib. It found that taking imatinib for 36 months significantly improved survival rates, and skipping the treatment often led to tumor return in patients with high-risk tumors. Patients with specific genetic mutations, particularly those with KIT exon 11 mutations, also saw better results from this extended treatment. Who this helps: This benefits patients with high-risk GISTs and their doctors by providing better treatment options.

Plain English
The study looked at an 82-year-old woman with Non-Hodgkin's Lymphoma who had surgery to remove part of her esophagus due to cancer. After the surgery, she developed a serious condition called chylothorax, which caused fluid to build up in her chest and required further surgery to fix. This highlights that patients with a history of Non-Hodgkin's Lymphoma may face greater risks after certain surgeries, making it important for doctors to be aware of this connection. Who this helps: This helps doctors and healthcare providers understand potential complications for patients with a history of Non-Hodgkin's Lymphoma.

Plain English
This study looked at the effectiveness of preoperative CT scans versus direct examination during laparoscopic splenectomy for finding accessory spleens, which can cause health problems if not detected. The researchers found that while 16 accessory spleens were discovered during surgery in 15 patients, the CT scans only identified 2 of these cases, making the CT scan accuracy a low 12.5%, compared to 100% accuracy during surgery. This matters because missing these accessory spleens can lead to a return of the patient's underlying blood condition. Who this helps: Patients undergoing splenectomy for blood disorders.

Plain English
This study examined complications like intestinal leaks that can happen after surgeries connecting parts of the intestine. Researchers found that the overall leak rate was 3.8%, with a much higher death rate of 13.3% in patients who had leaks compared to 1.7% in those who didn’t. The study discovered that open surgeries had a higher risk of leaks than minimally invasive (laparoscopic) ones, and factors like previous chemotherapy and blood loss during surgery also increased the risk. Who this helps: This information benefits doctors and patients by identifying risk factors that can help reduce complications during intestinal surgery.

Plain English
This study looked at a product called "Disoil" that uses special yeast to clean up oil spills in soil. It found that using this biodestructor reduces the oil content in the soil by 60-78% without making the soil more toxic. This is important because it shows a safe and effective way to restore polluted areas. Who this helps: This helps environmental cleanup agencies and communities affected by oil spills.